Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$985M |
| 3 |
Apple
AAPL
|
+$890M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$774M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$673M |
| 2 |
Bank of America
BAC
|
+$615M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$515M |
| 4 |
NVIDIA
NVDA
|
+$451M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$417M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.95% |
| 2 | Financials | 8.18% |
| 3 | Consumer Discretionary | 7.81% |
| 4 | Healthcare | 7.12% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Morningstar
MORN
$7.53B
| $6.82M | ﹤0.01% |
23,841
-74,242
| -76% | -$19.3M |
|
1827
California Resources
CRC
$4.62B
| $6.81M | ﹤0.01% |
124,455
+1,702
| +1% | +$89.5K |
|
1828
Iovance Biotherapeutics
IOVA
$2.87B
| $6.8M | ﹤0.01% |
836,175
+78,224
| +10% | +$409K |
|
1829
RadNet
RDNT
$5.69B
| $6.8M | ﹤0.01% |
195,464
+94,755
| +94% | +$2.99M |
|
|
GAP
1830
PUT
The Gap Inc
GAP
$7.37B
| $6.8M | ﹤0.01% |
+325,000
| New | +$5.24M |
|
|
COOP
1831
DELISTED
Mr. Cooper
COOP
| $6.8M | ﹤0.01% |
104,351
+71,322
| +216% | +$4.22M |
|
1832
Crinetics Pharmaceuticals
CRNX
$8.92B
| $6.8M | ﹤0.01% |
190,984
+77,702
| +69% | +$2.38M |
|
1833
Viavi Solutions
VIAV
$9.66B
| $6.77M | ﹤0.01% |
672,713
+528,783
| +367% | +$4.44M |
|
|
SAVE
1834
DELISTED
Spirit Airlines, Inc.
SAVE
| $6.77M | ﹤0.01% |
413,136
+64,220
| +18% | +$924K |
|
|
PARA
1835
PUT
DELISTED
Paramount Global Class B
PARA
| $6.76M | ﹤0.01% |
+457,200
| New | +$6.12M |
|
1836
DXC Technology
DXC
$1.73B
| $6.76M | ﹤0.01% |
295,655
-44,826
| -13% | -$998K |
|
1837
Beam Therapeutics
BEAM
$2.84B
| $6.76M | ﹤0.01% |
248,384
+50,737
| +26% | +$1.26M |
|
1838
Bausch Health
BHC
$2.34B
| $6.73M | ﹤0.01% |
838,786
+198,577
| +31% | +$1.45M |
|
1839
CVB Financial
CVBF
$3.99B
| $6.72M | ﹤0.01% |
332,978
+43,706
| +15% | +$776K |
|
1840
Independent Bank
INDB
$3.97B
| $6.72M | ﹤0.01% |
102,147
+32,861
| +47% | +$1.81M |
|
1841
PUT
Masco
MAS
$15.3B
| $6.7M | ﹤0.01% |
+100,000
| New | +$5.81M |
|
1842
Under Armour
UAA
$2.6B
| $6.69M | ﹤0.01% |
761,215
-676,253
| -47% | -$5.2M |
|
1843
Nutanix
NTNX
$16.9B
| $6.69M | ﹤0.01% |
140,203
+69,413
| +98% | +$2.81M |
|
1844
Agree Realty
ADC
$9.41B
| $6.68M | ﹤0.01% |
106,175
+51,616
| +95% | +$2.99M |
|
1845
PUT
Biogen
BIIB
$30.7B
| $6.68M | ﹤0.01% |
25,800
+18,200
| +239% | +$4.47M |
|
1846
CALL
Lincoln National
LNC
$8.81B
| $6.68M | ﹤0.01% |
+247,500
| New | +$5.95M |
|
1847
Sonos
SONO
$1.85B
| $6.67M | ﹤0.01% |
389,346
+74,455
| +24% | +$1M |
|
1848
Murphy USA
MUSA
$9.61B
| $6.67M | ﹤0.01% |
18,705
-787
| -4% | -$285K |
|
1849
Evercore
EVR
$11.8B
| $6.66M | ﹤0.01% |
38,937
+10,644
| +38% | +$1.54M |
|
|
P
1850
Everpure Inc
P
$29.9B
| $6.66M | ﹤0.01% |
186,725
+5,429
| +3% | +$190K |
|
Similar funds
Barclays's Q4 2023 Portfolio in Review
As of Q4 2023, Barclays held 5,469 positions worth $273B, up 70% from $161B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays deployed $85.1B of net new capital in Q4 2023, opening 898 new positions and adding to 2,915 existing holdings. Its largest new stake was AngloGold Ashanti: 9,667,894 shares worth $181M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $673M trimmed.
- Barclays's largest Q4 2023 buy was AngloGold Ashanti: 9,667,894 shares worth $181M.
- Barclays added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.51B increase.
- Barclays's biggest Q4 2023 reduction was CRH, cutting an estimated $673M.
- Barclays fully exited Activision Blizzard in Q4 2023, selling an estimated $417M.
- Barclays's ten largest holdings make up 27% of its $273B portfolio in Q4 2023.
- Barclays opened 898 new positions and closed 253 in Q4 2023.
- Barclays's portfolio value rose 70% quarter-over-quarter to $273B.
Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.